Hsbc Holdings PLC Novavax Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Novavax Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 10,587 shares of NVAX stock, worth $83,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,587

Previous 23,265 54.49%

Holding current value

$83,954

Previous $294,000 54.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $135,781 - $216,920	-12,678 Reduced 54.49%	10,587 $133,000
Q2 2024 Aug 12, 2024	BUY	$3.89 - $20.97 $1,240 - $6,689	319 Added 1.39%	23,265 $294,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $30,775 - $49,273	8,185 Added 55.45%	22,946 $109,000
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $27,921 - $39,934	-4,100 Reduced 21.74%	14,761 $106,000
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $6,316 - $9,015	-947 Reduced 4.78%	18,861 $140,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $7,228 - $15,662	-1,255 Reduced 5.96%	19,808 $137,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $142,663 - $403,194	-16,102 Reduced 43.33%	21,063 $216,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $11,393 - $47,651	-626 Reduced 1.66%	37,165 $693,000
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $1.91 Million - $3.97 Million	-52,681 Reduced 58.23%	37,791 $1.97 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $64.1 Million - $131 Million	-919,774 Reduced 91.04%	90,472 $6.66 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $132 Million - $214 Million	983,434 Added 3667.89%	1,010,246 $145 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $1.04 Million - $1.58 Million	5,825 Added 27.76%	26,812 $5.59 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $1.98 Million - $4.21 Million	16,348 Added 352.4%	20,987 $4.46 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $827,578 - $2.34 Million	-7,325 Reduced 61.23%	4,639 $841,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $784,329 - $1.39 Million	9,961 Added 497.3%	11,964 $1.33 Million
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $340,559 - $765,272	-4,287 Reduced 68.16%	2,003 $221,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $87,179 - $525,906	6,290 New	6,290 $524,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $620M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Novavax Inc Transaction History